Medicine
Oxytrol 3.9 mg/day transdermal patch
Oxytrol 3.9 mg/day transdermal patch is a prescription medicine containing Oxybutynin for transdermal use, marketed by Allergan, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20-25°C (68-77°F). Protect from moisture and humidity. Do not store…
Key facts
- Active ingredient (INN)
- Oxybutynin
- Brand
- Oxytrol
- Strength
- 3.9 mg/day
- Dosage form
- Transdermal patch
- Route
- Transdermal
- Packs
- 8 pouches
- Marketing authorisation holder
- Allergan
- Manufacturer
- Allergan
- Origin register
- US FDA, United States
- Storage
- Store at 20-25°C (68-77°F). Protect from moisture and humidity. Do not store outside the sealed pouch.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- G04BD04 Oxybutynin
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 26 February 2003
- Identifiers
- RxCUI 403799, 404448DailyMed set ID 20dee37f-1412-44ed-9e8b-f4379ce23eb0NDC 0023-6153Application NDA021351
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 8 pouch in 1 box / 1 patch in 1 pouch / 4 d in 1 patch | 0023-6153-08 | Allergan | 26 February 2003 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Oxybutynin
Clinical summary
Oxybutynin is a cholinergic muscarinic antagonist indicated for the treatment of overactive bladder in men with symptoms of urge urinary incontinence, urgency, and frequency. It is available as extended-release tablets, tablets and oral solution for transdermal use. MedsAcross supplies Oxybutynin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about OxybutyninFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- OXYTROL prescribing information (Allergan) · U.S. National Library of Medicine, DailyMed
- Kentera (previously Oxybutynin Nicobrand): European public assessment report (EPAR) · European Medicines Agency
Need Oxytrol 3.9 mg/day transdermal patch for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.